Recommendation: HOLD · Rating 6.0/10
The TVRI11 is in a race against the clock: it has ~4 years to recycle 50+ BB branches before their concentrated maturity in Nov/2027 becomes an acute problem. Tivio Capital proved itself through 9 sales (~R$ 200M, average premium of 42%) and in Aug/2026 early-renewed 3 contracts for 10 years (through 2036). However, the pace must continue: renewals covered only 3.33% of revenue, and recurring earnings dropped to R$ 0.93/unit — below the R$ 1.05 dividend.
The discount to BV (R$ 100.43) reflects this tension. Positive signs: Hortifruti and Day Hospital through 2035–2037, Ipiranga re-leased after 4 years vacant, reserves rising to R$ 0.82/unit. But Edifício Sede III concentrates 21% of revenue — if BB returns this property, the impact is catastrophic. Vacancy rose to 7% in Jul/2026.
For investors: a trade-off between discount to BV + 13.6% dividend yield + execution quality vs. concentration risk + the Nov/2027 race + DPU currently reliant on non-recurring items. Horizon of 4–6 years.
Our current reading of TVRI11 is HOLD, with a score of 6.0/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.
7th of 11: 50+ ex-BB properties across 14 states, with active management rotating tenants and lowering vacancy (re-leased Ipiranga and CACEX). Dividend yield of 13.2%, but 90% of contracts mature in Nov/2027 and Edifício Sede III concentrates 21% of revenue. HOLD.R$ 0.67/unit retained (~4.5 months of DPU) + R$ 0.76/unit in receivables from sales. This cushion allows stable DPU through late 2027 even as vacancy rises. But it is a finite cushion — depleted in 2028 if the gap is not closed by new leases.
The IPCA+8.75% CRI of R$ 35.1M assumed alongside Bluerock FII is debt of the Bluerock vehicle — if the UNIMED lease fails to pay, the CRI forecloses on the asset through Bluerock. TVRI11 would lose the R$ 21.6M invested in the units. It is not debt on TVRI11's balance sheet, but it is real economic exposure.
The buyer of Ag. Brás is behind on 3 installments in 2026 (R$ 13.5M receivable). If Tivio sells more properties with installment payment terms and experiences further delinquencies, the projected capital gains (R$ 0.76/unit receivable) may not materialize on schedule.
Even if BB renews 100% of standard leases in Nov/2027, the renewal will be at market rent — historically 10-20% below current values (the residual of the original atypical lease). Direct impact on post-2027 DPU.
| Scenario | Description |
|---|---|
| BB renews 70%+ of leases in Nov/2027 | Maintains the majority of the flow, complemented by Hortifruti + Day Hospital + ongoing recycling. |
| Tivio executes 5+ sales/year through 2027 | Continuation of current pace: 4 sales/year with an average premium of 42% over appraisal. |
| P/BV convergence to 1.00 | Reconvergence to 1.00 (already achieved in Jan/26). Total return of 21% in 12-18 months. |
| BB returns 30%+ of properties in Nov/2027 | Vacancy jumps to 30%+. Retained earnings reserves plus rapid recycling absorb only part of it. DPU may drop to R$ 0.75-0.80. |
| ED. Sede III returned alone | 21% of revenue. DPU falls 21% without immediate replacement. Recycling a property of this size requires 6-18 months. |
| Delinquency spreads (installment sales) | If another 2-3 installment sales fail, the R$ 0.76/unit receivable turns into judicial foreclosure — taking years to recover. |
TVRI11 is a rare case of an FII undergoing an explicit metamorphosis: it started in 2012 as a passive vehicle designed for a single client (BB) with a set maturity, and since 2023 it has been recreated by Tivio Capital in plain view of the market. Early results are consistent — 8 sales at 42% above appraisal, R$ 162.7M unlocked, 2 strategic acquisitions (Hortifruti, Day Hospital) that extend WAULT to 2035-2037 and diversify into retail and healthcare. The 3rd place in the 2026 InfoMoney Outliers Awards, Brick-and-Mortar FII category recognizes this work.
However, the thesis has an expiration date marked in red: Nov/2027. In that month, ~90% of leases with BB expire. Edifício Sede III alone concentrates 21% of revenue. If BB renews everything, great — sustainable DPU. If BB returns 30%, even with retained earnings reserves plus receivables, DPU could drop from R$ 1.05 to R$ 0.80 or less. The 7 early termination notices already received (CACEX Building, SJ Rio Preto, Tamoios, Cinelândia, Bauru, Belém, +1) are a clear signal that BB is reducing its physical footprint — and this is likely to intensify.
The P/BV of 0.91 adequately reflects this risk. It is not a bargain (P/BV of similar peers like TRXF11 and ALZR11 is at 0.96-0.98), but it is not expensive either. The 13.3% dividend yield is the second highest among comparable brick-and-mortar funds and includes ~10% in capital gains (sales) that will decrease as the portfolio recycles. For those willing to follow active transformation for 4-6 years, there is value. For those who need predictability, there are better funds.
Current recommendation: HOLD. Rating 6.0/10. The TVRI11 leases 57 physical properties — Banco do Brasil branches and offices across 14 states — and distributes rental income monthly, exempt from income tax for individual investors. Manager Tivio Capital (3rd place InfoMoney Outliers 2026) has been selling BB properties…
Our current read on TVRI11 is “HOLD”. Rating 6.0/10. Assess it against your risk profile and the points of attention listed above.
The main points of attention for Tivio Renda Imobiliária FII include: 90% of contracts mature in Nov/2027; BB has notified early termination of 7 branches; New lease for Ipiranga — vacant since 2022 — lowers projected vacancy; CACEX re-leased in May/2026 — physical vacancy drops from 5.7% to 3.2%.
TVRI11 is suitable for: Investors who understand they are paying R$ 0.91 for R$ 1.00 of BV in exchange for 4 years of high uncertainty Those seeking a 13%+ dividend yield and accepting that part comes from capital gains (sales) that will taper off Patient unitholders willing to wait for the metamorphosis to complete — 4–6 year horizon